학술논문
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: A real-world outcomes analysis
Document Type
Article
Author
Source
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 17 January 2023, 11(1))
Subject
Language
English
ISSN
20511426